Latest ECTRIMS Future Focus News
Developing a Consensus on Smoldering MS
Fifteen multiple sclerosis (MS) experts from eight countries across Europe, U.S., and…
New Data on CD40 Ligand Inhibitor for Relapsing MS
Treatment with the investigational CD40 ligand inhibitor frexalimab significantly reduced new MRI…
Multiple Sclerosis: Treat Early With High-Efficacy Therapy
At the joint meeting of the European Committee for Treatment and Research…
Multiple Sclerosis: Paving the Way to a Cure
At the joint meeting of the European Committee for Treatment and Research…
